Amy Walker Purchases 2,650 Shares of 4basebio (LON:4BB) Stock

4basebio PLC (LON:4BB) insider Amy Walker acquired 2,650 shares of the business’s stock in a transaction dated Friday, February 13th. The stock was acquired at an average price of GBX 586 per share, for a total transaction of £15,529.

4basebio Stock Performance

Shares of LON:4BB opened at GBX 569.75 on Monday. The company has a current ratio of 2.73, a quick ratio of 3.52 and a debt-to-equity ratio of 201.47. 4basebio PLC has a 12-month low of GBX 520 and a 12-month high of GBX 1,220. The business has a 50 day moving average of GBX 600.82 and a two-hundred day moving average of GBX 730.53. The company has a market capitalization of £88.23 million, a PE ratio of -5.76 and a beta of 1.09.

About 4basebio

4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients.

Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation.